menu
    • menu

    Company profile for Vivoryon Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vivoryon Therapeutics has two decades of successful history in bringing pharmaceutical innovation to patients in need. Our programs are based on dedicated research, top-level discovery and determined development. We develop first-in-class medicines that target post-translational modifying enzymes. Our pipeline contains several product candidates across various stages of development, focused on Alzheimer’s Disease and oncolog...
    Vivoryon Therapeutics has two decades of successful history in bringing pharmaceutical innovation to patients in need. Our programs are based on dedicated research, top-level discovery and determined development. We develop first-in-class medicines that target post-translational modifying enzymes. Our pipeline contains several product candidates across various stages of development, focused on Alzheimer’s Disease and oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vivoryon TherapeuticsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Halle (Saale) Vivoryon Therapeutics AG Weinbergweg 22 06120 Halle (Saale)
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vivoryon.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/probiodrug
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VivoryonAG

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vivoryon Therapeutics N.V. To Unveil Q3 2025 Financials
    Vivoryon Therapeutics N.V. To Unveil Q3 2025 Financials

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194014/0/en/Vivoryon-Therapeutics-N-V-to-Report-Q3-2025-Financial-Results-and-Operational-Progress-on-December-4-2025.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Vivoryon Presents Phase 2 Kidney Data At ASN Kidney Week 2025
    Vivoryon Presents Phase 2 Kidney Data At ASN Kidney Week 2025

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182889/0/en/Vivoryon-Therapeutics-N-V-Presents-Phase-2-Kidney-Function-and-Biomarker-Data-at-the-American-Society-of-Nephrology-Kidney-Week-2025.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Vivoryon Therapeutics N.V. Completes EUR 5.1M Private Placement
    Vivoryon Therapeutics N.V. Completes EUR 5.1M Private Placement

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3162044/0/en/Vivoryon-Therapeutics-N-V-Successfully-Completes-Private-Placement-Raising-EUR-5-1-Million.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Vivoryon Therapeutics N.V. to Present H1 2025 Financials
    Vivoryon Therapeutics N.V. to Present H1 2025 Financials

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139707/0/en/Vivoryon-Therapeutics-N-V-to-Report-H1-2025-Financial-Results-and-Operational-Progress-on-September-4-2025.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    Vivoryon Therapeutics N.V. to Present at Investor Conferences
    Vivoryon Therapeutics N.V. to Present at Investor Conferences

    27 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/27/3106352/0/en/Vivoryon-Therapeutics-N-V-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    27 Jun 2025
    Share Share
    Vivoryon Therapeutics N.V. Reports 2025 Annual General Meeting
    Vivoryon Therapeutics N.V. Reports 2025 Annual General Meeting

    24 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/24/3104266/0/en/Vivoryon-Therapeutics-N-V-Reports-Outcome-of-2025-Annual-General-Meeting.html

    GLOBENEWSWIRE
    24 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search